Rosen Ilan 4
Research Summary
AI-generated summary
Ceragon (CRNT) Director Ilan Rosen Receives RSUs and Options
What Happened
Ilan Rosen, a director of Ceragon Networks Ltd. (CRNT), was awarded equity compensation in late May 2026. The filing shows 9,770 RSUs settled into shares on 05/22/2026 and 22,120 RSUs settled into shares on 05/23/2026 (total 31,890 shares acquired). In addition, Rosen was granted stock options on 05/22/2026 (19,540 options) and 05/23/2026 (44,240 options) — 63,780 options in total. All items were reported with $0 consideration. The RSUs were fully vested and automatically converted to ordinary shares on grant; the options were granted fully vested and immediately exercisable. These entries are awards/grants (compensation), not open‑market purchases or sales.
Key Details
- Transaction dates: RSU settlements 05/22/2026 (9,770) and 05/23/2026 (22,120); option grants 05/22/2026 (19,540) and 05/23/2026 (44,240).
- Consideration reported: $0.00 for all grants.
- Shares acquired via RSU settlement: 31,890 shares. Options granted (derivative): 63,780 options (fully vested/exercisable on grant).
- Shares owned after transaction: not specified in the Form 4 filing.
- Footnotes: F1–F2 explain RSUs were vested and automatically settled into shares; F3–F4 state options were fully vested and immediately exercisable on grant.
- Filing: Form 4 filed 05/26/2026 covering transactions on 05/22 and 05/23; the filing does not include a late‑filing notation.
Context
- RSU settlements mean Rosen received ordinary shares as compensation (no cash outlay).
- The options are grants (derivative securities) and are already exercisable per the filing; the filing does not show any exercises or subsequent sales.
- Awards like these are common compensation tools and do not by themselves indicate an insider buying or selling stock in the open market.